Ticker
LEXXCompany Name
LEXARIA BIOSCIENCE CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -11.27M | $ -0.62 | 1 | 18.3M |
3/31/2025 | $ -9.28M | $ -0.53 | 1 | 17.51M |
12/31/2024 | $ -7.2M | $ -0.43 | 1 | 16.67M |
9/30/2024 | $ -5.68M | $ -0.46 | 1 | 12.38M |
6/30/2024 | $ -4.63M | $ -0.33 | 1 | 13.86M |
3/31/2024 | $ -5.24M | $ -0.49 | 1 | 10.77M |
12/31/2023 | $ -5.91M | $ -0.65 | 1 | 9.05M |
9/30/2023 | $ -6.52M | $ -0.99 | 1 | 6.61M |
6/30/2023 | $ -6.89M | $ -1.07 | 1 | 6.44M |
3/31/2023 | $ -6.9M | $ -1.16 | 1 | 5.95M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for LEXARIA BIOSCIENCE CORP is calculated as follows: EBITDA [ $ -3.97M ] / (Shares WA [ 2.77M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.43 ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |